Literature DB >> 22068351

Serum levels of TNF-α, IL-1β, COMP, and CTX-II in patients with Kashin-Beck disease in Sichuan, China.

Xin Tang1, Zongke Zhou, Bin Shen, Jing Yang, Pengde Kang, Jian Li, Nicolas Crook, Qi Li, Li Min, Fuxing Pei.   

Abstract

The aim of the study was to detect differences in serum levels of interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α), cartilage oligomeric matrix protein (COMP), type II collagen (CTX-II) between patients with Kashin-Beck disease (KBD) or osteoarthritis (OA) and to assess the correlation between these differences with the clinical grade of KBD. A total of one hundred fifty adult serum samples were collected; these samples belonged to the KBD group (n = 64), the OA group in KBD-prevalent areas (n = 47) and a healthy control group in non-KBD area (n = 39). Serum levels of TNF-α, IL-1β, COMP, and CTX-II were determined by a sandwich enzyme-linked immunosorbent assay, and the results were compared among the 3 groups (KBD/OA/normal) and between the different grades of KBD as well. The serum levels of IL-1β, TNF-α, COMP, and CTX-II were significantly higher in the KBD and OA group than the healthy adult group (P < 0.001), and TNF-α and IL-1β levels in the KBD group were similar to the OA group (for TNF-α, 14.38 ± 7.42 pg/ml vs. 12.61 ± 4.00 pg/ml, respectively, [P = 0.29]; for IL-1β, 141.53 ± 71.35 pg/ml vs. 135.61 ± 68.60 pg/ml, respectively, [P = 0.63]). However, the COMP level was significantly lower and the CTX-II level was higher in the KBD group than in the OA group (for COMP, 7.03 ± 3.11 ng/ml vs. 9.20 ± 3.51 ng/ml, respectively, [P = 0.003]; for CTX-II, 2.23 ± 0.79 ng/ml vs. 1.80 ± 0.87 ng/ml, respectively, [P = 0.026]). Moreover, no significant correlations were found between clinical grade and serum levels of TNF-α, IL-1β, COMP, and CTX-II for the 3 grades of KBD patients (P = 0.645, 0.481, 0.832, and 0.270, respectively). This study showed that serum levels of COMP in KBD patients decreased and CTX-II levels increased compared with the levels in OA patients, but TNF-α and IL-1β levels in KBD and OA group were similar. In addition, increased serum levels of TNF-α, IL-1β, COMP, and CTX-II were not associated with the KBD grade.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22068351     DOI: 10.1007/s00296-011-2172-8

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  32 in total

1.  Effects of physical environment on the evolution of Kashin-Beck disease in Tibet.

Authors:  M Hinsenkamp; F Mathieu; W Claus; J-F Collard; V de Maertelaer
Journal:  Int Orthop       Date:  2009-03-17       Impact factor: 3.075

2.  Blocking of TNF-alpha and IL-1 inhibits leukocyte infiltration at early, but not at late stage of S. aureus-induced arthritis and the concomitant cartilage destruction in rabbits.

Authors:  M Kimura; A Matsukawa; S Ohkawara; K Takagi; M Yoshinaga
Journal:  Clin Immunol Immunopathol       Date:  1997-01

3.  Up-regulation of cartilage oligomeric matrix protein at the onset of articular cartilage degeneration in a transgenic mouse model of osteoarthritis.

Authors:  H Salminen; M Perälä; P Lorenzo; T Saxne; D Heinegård; A M Säämänen; E Vuorio
Journal:  Arthritis Rheum       Date:  2000-08

Review 4.  Osteoarthritis: diagnosis and therapeutic considerations.

Authors:  Ralph Hinton; Ron L Moody; Alan W Davis; Sean F Thomas
Journal:  Am Fam Physician       Date:  2002-03-01       Impact factor: 3.292

5.  Increased urinary excretion of C-telopeptides of type II collagen (CTX-II) predicts cartilage loss over 21 months by MRI.

Authors:  E B Dam; I Byrjalsen; M A Karsdal; P Qvist; C Christiansen
Journal:  Osteoarthritis Cartilage       Date:  2008-09-03       Impact factor: 6.576

6.  Comparative analysis of gene expression profiles between the normal human cartilage and the one with endemic osteoarthritis.

Authors:  W Z Wang; X Guo; C Duan; W J Ma; Y G Zhang; P Xu; Z Q Gao; Z F Wang; H Yan; Y F Zhang; Y X Yu; J C Chen; M J Lammi
Journal:  Osteoarthritis Cartilage       Date:  2008-06-24       Impact factor: 6.576

7.  Chondrocyte apoptosis and expression of Bcl-2, Bax, Fas, and iNOS in articular cartilage in patients with Kashin-Beck disease.

Authors:  Shi Jie Wang; Xiong Guo; Hong Zuo; Yin Gang Zhang; Peng Xu; Zhi Guang Ping; Zentie Zhang; Dong Geng
Journal:  J Rheumatol       Date:  2006-03       Impact factor: 4.666

8.  Morphology and phenotype expression of types I, II, III, and X collagen and MMP-13 of chondrocytes cultured from articular cartilage of Kashin-Beck Disease.

Authors:  Weizhuo Wang; Xiong Guo; Junchang Chen; Peng Xu; Mikko J Lammi
Journal:  J Rheumatol       Date:  2008-03-01       Impact factor: 4.666

9.  Environmental Se-Mo-B deficiency and its possible effects on crops and Keshan-Beck disease (KBD) in the Chousang area, Yao County, Shaanxi Province, China.

Authors:  Weixuan Fang; Pengwu Wu; Ruizhong Hu; Zhuanying Huang
Journal:  Environ Geochem Health       Date:  2003-06       Impact factor: 4.609

10.  Cartilage Oligomeric Matrix Protein (COMP): A Biomarker of Arthritis.

Authors:  Susan Tseng; A Hari Reddi; Paul E Di Cesare
Journal:  Biomark Insights       Date:  2009-02-17
View more
  8 in total

Review 1.  Role of inflammation in the process of clinical Kashin-Beck disease: latest findings and interpretations.

Authors:  Jing Han; Weizhuo Wang; Chengjuan Qu; Ruiyu Liu; Wenrong Li; Zongqiang Gao; Xiong Guo
Journal:  Inflamm Res       Date:  2015-08-11       Impact factor: 4.575

Review 2.  Proteoglycan metabolism, cell death and Kashin-Beck disease.

Authors:  Siyuan Li; Junling Cao; Bruce Caterson; Clare E Hughes
Journal:  Glycoconj J       Date:  2012-06-26       Impact factor: 2.916

3.  Combined detection of serum CTX-II and COMP concentrations in osteoarthritis model rabbits: an effective technique for early diagnosis and estimation of disease severity.

Authors:  Bin Bai; Yanqin Li
Journal:  J Orthop Surg Res       Date:  2016-11-22       Impact factor: 2.359

4.  Chondroprotective Effects and Multitarget Mechanisms of Fu Yuan Capsule in a Rat Osteoarthritis Model.

Authors:  Li Zeng; Cai Zhi Xiao; Zi Ting Deng; Rong Heng Li
Journal:  Evid Based Complement Alternat Med       Date:  2017-01-11       Impact factor: 2.629

5.  Correlation Analysis of C-terminal telopeptide of collagen type II and Interleukin-1β for Early Diagnosis of Knee Osteoarthritis.

Authors:  Cai-Xia Liu; Ge Gao; Xiao-Qun Qin; Chang-Qing Deng; Xiong-Jie Shen
Journal:  Orthop Surg       Date:  2019-12-16       Impact factor: 2.071

6.  The efficacy and safety of intra-articular injection of hyaluronic acid in the knee and physical therapy agents to treat Kashin-Beck disease: A prospective interventional study.

Authors:  Pinglin Yang; Xiong Guo; Xijing He; Quanjin Zang; Guoyu Wang; Peng Xu; Weizhuo Wang
Journal:  Exp Ther Med       Date:  2016-05-19       Impact factor: 2.447

7.  Long noncoding RNA expression profile reveals lncRNAs signature associated with extracellular matrix degradation in kashin-beck disease.

Authors:  Cuiyan Wu; Huan Liu; Feng'e Zhang; Wanzhen Shao; Lei Yang; Yujie Ning; Sen Wang; Guanghui Zhao; Byeong Jae Lee; Mikko Lammi; Xiong Guo
Journal:  Sci Rep       Date:  2017-12-14       Impact factor: 4.379

8.  Decreased Plasma COMP and Increased Plasma CTX-II Levels in a Chinese Pseudoachondroplasia Family with Novel COMP Mutation.

Authors:  Chongjuan Gu; Zhao Yang; Hao Tan; Yingying Zhang; Yilu Lu; Yongxin Ma
Journal:  Biomed Res Int       Date:  2017-08-27       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.